在12个月的随访后,与炎症生物标志物相比,多伦多IBD全球内镜报告得分的构造有效性
Eran Zittan1,2,3, Matthew Levy1,2, Shiraz Vered4
1The Abraham and Sonia Rochlin IBD Unit, Department of Gastroenterology and Liver Diseases, Emek Medical Center, Afula, Israel.
Inflammatory bowel diseases
|July 8, 2025
概括
多伦多IBD全球内镜报告 (TIGER) 评分有效预测便calprotectin和克罗恩氏病C反应蛋白等炎症标志物.
科学领域:
- 胃肠病学和肝病学
- 炎症性肠病 (IBD) 研究研究
- 临床内镜和生物标志物验证
背景情况:
- 多伦多IBD全球内镜报告 (TIGER) 评分是评估克罗恩病 (CD) 和性结肠炎 (UC) 内镜活动的统一指数.
- 目前对IBD的评估通常依赖于炎症标志物和内镜评估,需要验证的评分系统.
研究的目的:
- 评估基线TIGER分数与12个月后便calprotectin (FC) 和C反应蛋白 (CRP) 的随后水平之间的直接相关性.
- 确定TIGER评分对IBD患者持续炎症活动的预测值.
主要方法:
- 一项长达12个月的前性研究,涉及107名成人患者 (52名CD,55名UC) 在第三级IBD中心.
- 进行了基线结肠镜检查,以确定TIGER,克罗恩病简单内镜评分 (SES-CD) 和梅奥内镜评分 (MES) 的值.
- 在整个研究过程中,便中calprotectin (FC) 和C-反应蛋白 (CRP) 水平被监测,基线内镜评分被用作12个月结果的预测指标.
主要成果:
- 基线TIGER评分≥100显示高灵敏度 (0.964) 和特异性 (0.941) 在预测12个月升高的FC (≥800μg/g) 和/或CRP (≥1.0 mg/dL).
- 较高的基线TIGER分数 (≥100) 与12个月后FC水平升高 (>100μg/g和>800μg/g) 的可能性增加显著相关,无论先进治疗如何.
- 在SES-CD和MES中观察到类似的预测趋势,支持TIGER评分的构造有效性.
结论:
- TIGER评分是对CD和UC的验证,简单的内镜工具,与炎症标志物有很强的相关性.
- 与已建立的内镜评分系统相比,TIGER评分在12个月的随访期间表现出非劣势.
- 建议将TIGER评分纳入未来的临床试验,以测量IBD管理中的治疗反应.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
428
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
428
01:30Inflammatory Bowel Disease II: Crohn's Disease
395
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
395
01:21Inflammatory Bowel Disease V: Surgical Management
221
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
221
01:29Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
253
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
253
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
334
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
334